Maternal and Neonatal SARS-CoV-2 Omicron Variant Neutralization after Antenatal mRNA Vaccination

alexandrossfakianakis shared this article with you from Inoreader Maternal and Neonatal SARS-CoV-2 Omicron Variant Neutralization after Antenatal mRNA Vaccination via Clinical Infectious Diseases Advance Access Abstract We evaluated the neutralization efficiency against SARS-CoV-2 omicron variant in maternal and cord blood sera after antenatal BNT162b2 vaccination. Neutralizing antibodies against omicron were lacking at the time of delivery after two-dose vaccination. A third booster dose was essential in building neutralizing antibody capacity against omicron among mothers and neonates. View on Web

Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.